HCPCS J7335: Capsaicin 8% Patch, per 10 sq cm

HCPCS Level II code J7335 denotes the capsaicin 8% patch billed per 10 square centimeters, a high-concentration topical therapy used for localized neuropathic pain. Nationally, this code matters because it represents a specialty topical drug that can involve procedure time, application logistics, and payer-specific coverage rules that affect access and patient out-of-pocket costs.

This analysis covers major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, typical billing and coding considerations, and the clinical context for use of the capsaicin 8% patch. The content includes benchmarks where available, notes on policy updates that affect coverage and prior authorization, and practical billing pointers relevant to the service line.

Clinically, the patch is used in outpatient settings for targeted neuropathic pain relief, often after other topical or systemic therapies. The publication outlines the code definition, typical sites of service, and what to expect from payers regarding reimbursement structure and documentation requirements. Data gaps from the input are noted where applicable. The goal is to provide a concise reference for billing managers, clinicians, and revenue cycle staff handling high-concentration topical analgesic applications billed with J7335.

Billing Code Overview

HCPCS Level II code J7335 represents the capsaicin 8% patch, billed per 10 square centimeters. The service is a topical high-concentration capsaicin application, used for localized neuropathic pain management.

Service type: Topical medication patch application (high-concentration capsaicin)
Typical site of service: Outpatient clinic or physician office where topical procedures and prescription drug administrations are performed

Data not available in the input.

Clinical Context

A typical patient is an adult with localized neuropathic pain such as postherpetic neuralgia affecting a discrete skin area. The patient has failed or has contraindications to first-line topical therapies and systemic agents, and the clinician elects treatment with a high-concentration topical capsaicin 8% patch (J7335) applied to the painful area during an outpatient dermatology, pain management, or neurology clinic visit. Prior to application the treatment area is assessed, photographed, and prepared by cleaning and measuring the surface area in square centimeters so the correct number of patches is used. Local analgesia (topical anesthetic or regional block) may be provided before patch application to reduce procedure-related pain. The patch is applied for the manufacturer-recommended duration (typically 30–60 minutes depending on location) while the patient is monitored for discomfort or adverse reactions. After removal, the treated area is cleansed and the used patch is disposed of as biohazardous waste per facility policy. The clinician documents baseline pain score, treated area size, time applied, any local anesthesia or monitoring, and follow-up plan for pain reassessment and potential repeat application at recommended intervals.

Coding Specifications

Modifier	Description	When to Use
`59`	Distinct procedural service	When a separate and distinct service/procedure is provided on the same day by the same provider that is not normally reported together with the capsaicin patch application

Taxonomy Code	Specialty	Notes
`207P00000X`	Pain Medicine	Common specialty performing high-concentration topical analgesic applications in outpatient pain clinics
`207N00000X`	Neurology	Treats neuropathic pain syndromes such as postherpetic neuralgia or neuropathic limb pain
`208D00000X`	Dermatology	Applies topical treatments and manages localized neuropathic pain involving skin
`208800000X`	Physical Medicine & Rehabilitation	Manages chronic pain and coordinates multimodal therapies
`363L00000X`	Nurse Practitioner	Often performs patch application under supervising physician protocols

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G53.0`	Postherpetic neuralgia	Primary indication for capsaicin 8% patch to reduce localized neuropathic pain following herpes zoster
`G58.0`	Complex regional pain syndrome I	Localized neuropathic pain conditions where high-concentration capsaicin may be considered as part of multimodal therapy
`G58.1`	Complex regional pain syndrome II	Neuropathic pain of peripheral nerve origin potentially treated with topical analgesics
`M79.2`	Neuralgia and neuritis, unspecified	General neuralgic pain presentations treated with topical high-concentration capsaicin where appropriate
`G89.2`	Chronic pain, not elsewhere classified	Chronic localized neuropathic pain conditions that may be treated with capsaicin patch therapy

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99070`	Supplies and materials (e.g., drugs, devices, biologics) used directly by the physician office; list separately in addition to other codes	Used to bill additional non-covered supplies or materials associated with patch application when payer allows separate supply reimbursement
`97032`	Application of a modality to one or more areas; electrical stimulation (manual), each 15 minutes	May be performed in the same clinic visit as adjunctive physical modalities for pain management (billing dependent on payer rules)
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Used if a regional block or local anesthetic injection is administered prior to patch application to reduce treatment discomfort
`99401`	Preventive medicine counseling and/or risk factor reduction intervention(s) counseling; individual, 15 minutes	May be used for counseling on pain self-management and safety after patch application when separately documented
`99000`	Handling and/or conveyance of specimen for transfer from patient to laboratory (historical; rarely used)	Not routinely used; included here for situations where ancillary specimen handling occurs in the same visit

OpenPayer

Summary & Overview